A detailed history of California Public Employees Retirement System transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, California Public Employees Retirement System holds 211,756 shares of IONS stock, worth $7.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
211,756
Previous 196,484 7.77%
Holding current value
$7.2 Million
Previous $9.36 Million 9.42%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$40.06 - $51.86 $611,796 - $792,005
15,272 Added 7.77%
211,756 $8.48 Million
Q2 2024

Aug 14, 2024

SELL
$36.45 - $47.7 $271,953 - $355,889
-7,461 Reduced 3.66%
196,484 $9.36 Million
Q1 2024

Apr 30, 2024

SELL
$42.03 - $53.55 $230,786 - $294,043
-5,491 Reduced 2.62%
203,945 $8.84 Million
Q4 2023

Feb 01, 2024

SELL
$43.39 - $51.63 $19.3 Million - $23 Million
-445,935 Reduced 68.04%
209,436 $10.6 Million
Q3 2023

Nov 02, 2023

BUY
$38.5 - $47.13 $15.3 Million - $18.8 Million
397,897 Added 154.54%
655,371 $29.7 Million
Q2 2023

Aug 09, 2023

SELL
$34.73 - $43.33 $863,109 - $1.08 Million
-24,852 Reduced 8.8%
257,474 $10.6 Million
Q1 2023

May 12, 2023

SELL
$33.58 - $41.2 $1.6 Million - $1.96 Million
-47,511 Reduced 14.4%
282,326 $10.1 Million
Q4 2022

Feb 08, 2023

BUY
$37.12 - $46.52 $232,037 - $290,796
6,251 Added 1.93%
329,837 $12.5 Million
Q3 2022

Nov 09, 2022

BUY
$36.54 - $48.66 $1.51 Million - $2 Million
41,204 Added 14.59%
323,586 $14.3 Million
Q2 2022

Aug 10, 2022

SELL
$31.71 - $43.0 $394,250 - $534,619
-12,433 Reduced 4.22%
282,382 $10.5 Million
Q1 2022

May 04, 2022

BUY
$29.88 - $37.04 $310,483 - $384,882
10,391 Added 3.65%
294,815 $10.9 Million
Q4 2021

Feb 10, 2022

SELL
$25.61 - $35.1 $94,859 - $130,010
-3,704 Reduced 1.29%
284,424 $8.66 Million
Q3 2021

Nov 10, 2021

SELL
$33.54 - $40.55 $1.09 Million - $1.32 Million
-32,552 Reduced 10.15%
288,128 $9.66 Million
Q2 2021

Aug 13, 2021

BUY
$34.54 - $47.25 $141,717 - $193,866
4,103 Added 1.3%
320,680 $12.8 Million
Q1 2021

May 14, 2021

BUY
$42.51 - $63.78 $670,425 - $1.01 Million
15,771 Added 5.24%
316,577 $14.2 Million
Q4 2020

Feb 02, 2021

BUY
$45.3 - $60.27 $127,881 - $170,142
2,823 Added 0.95%
300,806 $17 Million
Q3 2020

Nov 05, 2020

BUY
$47.45 - $62.95 $346,717 - $459,975
7,307 Added 2.51%
297,983 $14.1 Million
Q2 2020

Aug 12, 2020

BUY
$46.85 - $61.05 $193,162 - $251,709
4,123 Added 1.44%
290,676 $17.1 Million
Q1 2020

May 12, 2020

SELL
$41.6 - $63.4 $669,760 - $1.02 Million
-16,100 Reduced 5.32%
286,553 $13.5 Million
Q4 2019

Jan 27, 2020

BUY
$53.85 - $65.27 $607,535 - $736,376
11,282 Added 3.87%
302,653 $18.3 Million
Q3 2019

Oct 31, 2019

BUY
$59.06 - $72.15 $4.37 Million - $5.34 Million
74,015 Added 34.05%
291,371 $17.5 Million
Q2 2019

Aug 15, 2019

BUY
$62.09 - $86.14 $431,401 - $598,500
6,948 Added 3.3%
217,356 $14 Million
Q1 2019

May 03, 2019

BUY
$52.92 - $81.17 $1.18 Million - $1.81 Million
22,285 Added 11.85%
210,408 $17.1 Million
Q4 2018

Feb 08, 2019

SELL
$43.37 - $59.54 $393,669 - $540,444
-9,077 Reduced 4.6%
188,123 $10.2 Million
Q3 2018

Nov 13, 2018

SELL
$42.88 - $53.7 $630,336 - $789,390
-14,700 Reduced 6.94%
197,200 $10.2 Million
Q2 2018

Aug 15, 2018

SELL
$40.53 - $50.7 $1.71 Million - $2.14 Million
-42,200 Reduced 16.61%
211,900 $8.83 Million
Q1 2018

May 11, 2018

SELL
$44.08 - $55.05 $537,776 - $671,610
-12,200 Reduced 4.58%
254,100 $11.2 Million
Q4 2017

Feb 06, 2018

BUY
$50.3 - $64.39 $2.18 Million - $2.79 Million
43,400 Added 19.47%
266,300 $13.4 Million
Q3 2017

Nov 15, 2017

BUY
$45.56 - $59.57 $10.2 Million - $13.3 Million
222,900
222,900 $11.3 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $4.83B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.